Home

opakovat Nevrlý Prozkoumat metastatic renal cancer overall survival over 20 years jednou hříšník Smírčí soudce

Frontiers | Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy  in Metastatic Clear Cell Renal Cancer
Frontiers | Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer

The Team That's Doubling Cancer Survival Rates | Cancer | UT Southwestern  Medical Center
The Team That's Doubling Cancer Survival Rates | Cancer | UT Southwestern Medical Center

The effect of the papillary renal cell carcinoma subtype on oncological  outcomes | Scientific Reports
The effect of the papillary renal cell carcinoma subtype on oncological outcomes | Scientific Reports

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma | NEJM
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma | NEJM

Renal cell carcinoma lung metastases treated by radiofrequency ablation  integrated with systemic treatments: over 10 years of experience | BMC  Cancer | Full Text
Renal cell carcinoma lung metastases treated by radiofrequency ablation integrated with systemic treatments: over 10 years of experience | BMC Cancer | Full Text

Renal Cell Cancer Treatment (PDQ®)–Health Professional Version - NCI
Renal Cell Cancer Treatment (PDQ®)–Health Professional Version - NCI

The number of metabolic features as a significant prognostic factor in  patients with metastatic renal cell carcinoma | Scientific Reports
The number of metabolic features as a significant prognostic factor in patients with metastatic renal cell carcinoma | Scientific Reports

Real-world efficacy and safety of nivolumab in previously-treated metastatic  renal cell carcinoma, and association between immune-related adverse events  and survival: the Italian expanded access program | Journal for  ImmunoTherapy of Cancer
Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program | Journal for ImmunoTherapy of Cancer

Overall survival for patients with progressive metastatic renal cell... |  Download Scientific Diagram
Overall survival for patients with progressive metastatic renal cell... | Download Scientific Diagram

Five-year overall survival curves of renal cell carcinoma patients... |  Download Scientific Diagram
Five-year overall survival curves of renal cell carcinoma patients... | Download Scientific Diagram

Frontiers | Real-World Metastatic Renal Cell Carcinoma Treatment Patterns  and Clinical Outcomes in The Netherlands
Frontiers | Real-World Metastatic Renal Cell Carcinoma Treatment Patterns and Clinical Outcomes in The Netherlands

Frontiers | Survival in Metastatic Renal Cell Carcinoma Patients Treated  With Sunitinib With or Without Cryoablation
Frontiers | Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation

Overall survival of 180 patients with metastatic renal cell carcinoma... |  Download Scientific Diagram
Overall survival of 180 patients with metastatic renal cell carcinoma... | Download Scientific Diagram

Cancers | Free Full-Text | The Effect of Age on Prostate Cancer Survival
Cancers | Free Full-Text | The Effect of Age on Prostate Cancer Survival

Creation of a biomarker-augmented metastases score - Mayo Clinic
Creation of a biomarker-augmented metastases score - Mayo Clinic

Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic  renal cell carcinoma: a randomized phase 1 trial | Nature Medicine
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial | Nature Medicine

Kaplan-Meier curve depicting the overall survival of 359 metastatic... |  Download Scientific Diagram
Kaplan-Meier curve depicting the overall survival of 359 metastatic... | Download Scientific Diagram

Long-term follow-up of overall survival for cabozantinib versus everolimus  in advanced renal cell carcinoma | British Journal of Cancer
Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma | British Journal of Cancer

Overall survival curves for (A) all 140 patients with metastatic renal... |  Download Scientific Diagram
Overall survival curves for (A) all 140 patients with metastatic renal... | Download Scientific Diagram

Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score  Analysis - Clinical Genitourinary Cancer
Benefit of Metastasectomy in Renal Cell Carcinoma: A Propensity Score Analysis - Clinical Genitourinary Cancer

Duration of First-line Treatment with Molecular Targeted-Therapy Is a  Prognostic Factor in Metastatic Renal Cell Carcinoma | Anticancer Research
Duration of First-line Treatment with Molecular Targeted-Therapy Is a Prognostic Factor in Metastatic Renal Cell Carcinoma | Anticancer Research

Changes in therapy and survival of metastatic renal cell carcinoma in  Estonia | BMC Cancer | Full Text
Changes in therapy and survival of metastatic renal cell carcinoma in Estonia | BMC Cancer | Full Text